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ABSTRACT 
Decreased bone formation is often associated with increased bone marrow adiposity. The 
molecular mechanisms that are accountable for the negative correlation between bone 
mass and bone marrow adiposity are incompletely understood. Focal adhesion kinase 
(FAK) has critical functions in proliferation and differentiation of many cell types; 
however, its roles in osteoblast lineage cells are largely unknown. We show herein that 
mice lacking FAK in Osterix-expressing cells exhibited decreased osteoblast number and 
low bone mass as well as increased bone marrow adiposity. The decreased bone mass in 
FAK-deficient mice was accounted for by decreased proliferation, compromised 
osteogenic differentiation, and increased adipogenic differentiation of bone marrow 
Osterix-expressing cells resulting from downregulation of Wnt/β-catenin signaling due to 
the reduced expression of canonical Wnt ligands. In contrast, FAK loss in calvarial 
preosteoblasts had no adverse effect on their prolife at on and osteogenic differentiation 
and these cells had intact Wnt/β-catenin signaling. © 2016 American Society for Bone 
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Introduction 
In patients who suffer from osteoporosis(1) or conditions that can induce bone loss such as 
disuse,(2) microgravity exposure,(3) and estrogen insufficiency,(4) bone marrow adiposity 
is often significantly increased. The insight into the molecular mechanisms underlying 
increased bone marrow adiposity can facilitate the development of therapy of these 
pathological conditions. 
 Bone marrow mesenchymal stromal/stem cells (BMSCs) can give rise to both 
osteoblasts, which are responsible for the bone formation, and adipocytes, which are 
responsible for the marrow fat formation.(5) Thus, the negative correlation between bone 
mass and marrow adiposity observed in osteopenic coditi ns suggests that the lineage 
progression of BMSCs into osteoblasts and adipocytes may be coordinated. One pathway 
implicated in the regulation of BMSC fate and the decision to differentiate to osteoblasts 
or adipocyte is the canonical Wnt signaling pathway.(6) 
 Wnt/β-catenin signaling plays important roles in both oste blastogenesis and 
adipogenesis.(6,7) Upon the binding of Wnt ligands to its Frizzled family receptors, β-
catenin is stabilized and translocated from the cytoplasm to the nucleus to stimulate the 
transcription of Wnt target genes.(7) Via this mechanism, Wnt/β-catenin signaling 









Besides its indispensable role in osteoblastogenesis, Wnt/β-catenin signaling is a potent 
suppressor of adipogenesis.(6) Importantly, two recent studies demonstrated important 
dual roles of Wnt/β-catenin signaling in bone mass and bone marrow adiposity 
regulation. Removal of β-catenin in Osterix-expressing cells leads to decreased bone 
mass and increased bone marrow adiposity.(9,10) 
 FAK is an intracellular non-receptor tyrosine kinase and a major mediator of 
signal transduction by integrins. Since its discovery in the early 1990s, numerous studies 
have shown a role for FAK in the regulation of cell spreading, adhesion, migration, 
survival, proliferation, and differentiation.(11,12) The role of FAK in skeletal development 
is largely unclear. It has been shown that FAK deletion in mature osteoblasts does not 
affect mouse bone development, although it compromises bone healing.(13) Because FAK 
signaling is hyperactive in many types of cancers, many pharmaceutical inhibitors of 
FAK have been developed in recent years.(14) Unfortunately, it is unknown to what extent 
FAK inhibition would impact bone health. We previously demonstrated that the 
inhibition of FAK kinase activity by a chemical inhibitor leads to compromised mouse 
bone marrow osteoblast differentiation.(15) This prompted us to determine to what extend 
FAK may regulate the function of early osteoblast lineage cells. To this end, we 
generated a FAK conditional knockout mouse model in which FAK was deleted in 
Osterix-expressing cells. We show that this targeted deletion leads to a decrease in bone 
mass associated with increased bone marrow adiposity and decreased Wnt/β-catenin 
mediated transcription. 
Materials and Methods 
Mice 
The floxed FAK (FAKflox/flox) mice were generated by us previously.(16) Osx-Cre 
transgenic mice were described previously(8) and obtained from Jackson laboratory (Bar 
Harbor, ME, USA). All mice were backcrossed for at least eight generations onto a 
C57BL/6 background. Mice were housed under pathogen-free conditions at 22 ± 2°C on 
a 12:12-hour light/dark cycle, fed with 5001 or 5008 (for mating units) rodent diet 
(LabDiet). Each mating unit has one male and two femal  mice. Male mice were 
euthanized by carbon dioxide overdose at 2 months of age for bone phenotyping studies, 









decapitation in primary calvarial osteoblast digestion experiments. All experimental 
procedures were carried out with the approval of the Institutional Animal Care and Use 
Committee at the University of Michigan. 
Immunohistochemistry 
Immunohistochemistry on paraffin sections was performed as described.(17) In brief, 
endogenous peroxidase was blocked by 0.3% H2O2/methanol for 30 min. Sections were 
then incubated with FAK primary antibody C20 (Santa Cruz Biotechnology, Santa Cruz, 
CA, USA; sc-558) overnight at 4°C. A horseradish peroxidase–streptavidin system 
(DAKO, Carpinteria, CA, USA) was used to detect immunoreactivity, which was 
followed by counterstaining with hematoxylin. 
RNA extraction and qRT-PCR 
Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA, USA) according 
to the manufacturer’s instructions. qRT–PCR analyses w re performed as described.(15) 
cDNA templates were subjected to qPCR using the SYBR Green PCR Core reagents 
system (Qiagen, Valencia, CA, USA). 18S rRNA was used as an internal control. 
Relative gene expression was calculated by the ∆Ct (the difference between the threshold 
cycles) method.(18) Primer sequences used for real-time PCR are available upon request. 
Micro–computed tomography analysis 
Femora were dissected and analyzed by micro–computed tomography (µCT) using an 
eXplore Locus SP (GE Healthcare Pre-Clinical Imaging, London, ON, Canada) as 
described.(15) Whole calvaria were dissected and analyzed as reported(19) with 
modifications. In brief, fixed threshold of 1800 Hounsfield Units was used to 
discriminate mineralized tissue. Regions of interest (ROIs) for parietal and frontal bones 
were established as 0.5 mm in length, 0.5 mm in width, epth equivalent to thickness of 
bone, and position starting at a 1 mm distance fromsagittal suture for both parietal and 
frontal bones, 1 mm distance from coronal suture fo parietal bone, and 1.5 mm for 
frontal bone, using the Advanced ROI tool. The genotype information of bone samples 
was blinded to the image analyzer. 
Histomorphometry 
Static histomorphometry were performed similar to that described.(15,20) All parameters 









Research Histomorphometry Nomenclature Committee.(21) The genotype information of 
bone samples was blinded to image analyzer. 
BMSCs culture 
BMSCs were obtained from bone marrow of 6-week-old t  8-week-old control or 
conditional knockout (CKO) mice. In brief, mice were euthanized and the femur and tibia 
were removed, cleaned of all connective tissue. The ends of each tibia and femur were 
cut and cells in bone marrow were flushed by α-MEM medium with 26G syringe. After 
centrifugation for 5 min at 1000g, cell pellets were resuspended in medium with 18G 
syringe followed by filtration through a 70-µm nylon mesh filter. Then 100 million cells 
were cultured in a 100-mm dish with 10 mL basic medium including α-MEM medium, 
10% fetal bovine serum (FBS), 100 U/mL penicillin, a d 100 mg/mL of streptomycin. 
Nonadherent cells were removed after 3 days by discarding 5 mL medium and adding 5 
mL of fresh basic medium. Every other day, cells were washed, and fresh medium was 
added for a period of 10 days. After confluence, cells were trypsinized by 0.25% 
trypsin/EDTA and 2 × 106 cells (passage 1) were plated in a 100-mm dish. The same 
conditions were used for the subsequent passages. 
BMSC osteogenic differentiation and histochemical assay 
BMSCs with the second passage were seeded in a 12-well plate at 1 × 105 per well. 
Twenty-four hours later (designated as day 0), the basic medium were removed and 
replaced by induction medium, which was basic medium containing 50 mg/mL of 
ascorbic acid and 10 mM of beta-glycerophosphate. Th  induction medium was changed 
every 2 days for 21 days. Alkaline phosphatase staining (ALP) was performed for 
osteoblast differentiation at day 7 using a commercial kit (Sigma Diagnostics, Livonia, 
MI, USA) according to the manufacturer’s instructions. Alizarin red staining (AR) was 
performed for mineralization analysis at day 21. In brief, cells were fixed with 70% ice-
cold ethanol for 1 hour, and stained with 40 mM alizarin red S, pH 4.2, for 10 min at 
room temperature with rotation. 
BMSC adipocyte differentiation 
BMSCs were seeded in a 12-well plate at 4 × 105 per well. On the second day (day 0), 
cells were incubated with adipogenic induction medium (basic medium containing 1 µM 









insulin) for 2 days and adipogenic maintenance medium (basic medium containing 1 
µg/mL insulin) for 3 days. Oil-red O staining was used to assess adipogenic 
differentiation at day 5. Briefly, cells were fixed with 10% formalin for 1 hour, and 
washed with 60% isopropanol to dehydrate. Then cells were stained with 0.2% Oil red O 
for 10 min at room temperature. After three washes with water, cells were visualized on 
light microscopy and photographed. To extract incorporated Oil red O, 1 mL 100% 
isopropanol was added to each well followed by 10-min gentle shaking at room 
temperature. The optical density (OD) values were colle ted at 500 nm. 
Primary calvarial osteoblast culture 
Calvarial cells were isolated from 1-day-old to 3-day-old transgenic mice. After removal 
of sutures, parietal bones were subjected to four sequential digestions as described.(15) 
Cells were plated at a density of 1.9 × 104 to 2.4 × 104 cells/cm2 in a 12-well plate in α-
MEM containing 10% FBS. For osteogenic differentiation, the medium was changed to 
differentiation medium after 1 week of culture as de cribed.(15) ALP and AR staining 
were performed at day 7 and day 21, respectively. 
Proliferation assay 
BMSCs from control and CKO mice were seeded in a 12-well plate at 1 × 105/well in 
differentiation medium. Cells were trypsinized 3 or 7 days later and cell numbers were 
counted. 
Ki67 staining 
Cells were fixed in 4% paraformaldehyde (wt/vol) for 20 min at room temperature and 
blocked in sheep serum. Then cells were incubated with primary antibody (Ki67; Cell 
Signaling Technology, Beverly, MA, USA) overnight at 4°C, washed three times with 
PBST, and then incubated with appropriate secondary antibody for 1 hour at room 
temperature. After three washes, cells were mounted with ProLong Gold Anti-fade 
Reagent with DAPI. Ki67-positive cells were quantified by Image J software 
(https://imagej.nih.gov/ij/). 
Western blot 
Cells were lysed in NP40 lysis buffer (PH 8.0 Tris-HCl 20 mM, NaCl 137 mM, 1% 
NP40, 10% glycerol, Na3VO4 1 mM) and boiled for 10 min. Protein extracts were 









and transferred onto polyvinylidene fluoride (PVDF) membrane (Millipore, Billerica, 
MA, USA; IPVH00010). Membranes were incubated with rabbit anti-FAK antibody 
(Santa Cruz Biotechnology), mouse anti-β-catenin antibody (BD Biosciences, San Jose, 
CA, USA), rabbit anti-p-GSK-3β antibody, rabbit anti-GSK-3β antibody, or mouse anti-
vinculin antibody (Sigma-Aldrich, St. Louis, MO, USA) at 4°C overnight. After washing 
in Tris-buffered saline Tween-20 (TBST), the membrane was incubated with horseradish 
peroxidase–conjugated secondary antibody: Goat anti-r bbit (Thermo Fisher Scientific, 
Rockford, IL, USA; 31460) or Goat anti-mouse antibody (Jackson ImmunoResearch, 
West Grove, PA, USA; 115-035-072) for 1 hour at room temperature. Membranes were 
developed with HPR substrate ECL (Millipore; WBKL S0500). Films were scanned 
using an Epson Perfection V700 photo system and bans were quantified with the optical 
density function of Image J software. 
Statistics 
Student’s t test was used to make comparison between the two groups. Differences were 
considered significant at p < 0.05. 
Results 
Deletion of FAK in Osterix+ cells leads to osteopenia in mice 
To assess the physiological function of FAK in early osteoblast lineage cells, we 
generated FAK CKO mice with Osx-Cre transgenic mice, which express Cre 
recombinase in osteoprogenitor cells.(8) Briefly, we mated floxed FAK (FAKF/F) mice 
(designated as control [CTR] mice) with Osx-Cre transgenic mice to generate 
FAKF/+;Osx-Cre mice (designated as CHet mice), which were mated with FAKflox/flox 
mice to generate CTR mice, CHet mice, and FAKflox/flox;Osx-Cre (CKO) mice. Littermate 
mice were used in all experiments. The body weight of CKO mice was less than that of 
both CTR and CHet mice (Supporting Fig. S1). To determine the deletion of FAK in 
CKO bones, immunostaining was performed in both femur and calvaria. FAK was 
efficiently deleted in most osteoblasts and osteocytes of CKO bones (Supporting Fig. S2). 
Next, we used µCT to evaluate the effects of FAK deletion on bone morphometry. µCT 
analysis revealed an osteopenic phenotype in CKO mice. In femoral trabecular bone of 
CKO mice, we observed a 32% decrease in trabecular bone volume (BV/TV) (Fig. 1A), a 









thickness (Tb.Th) (Fig. 1C), and a 42% increase in trabecular spacing (Tb.Sp) (Fig. 1D) 
compared to CTR mice. Of note, the difference in these parameters between CTR and 
CHet mice is not statistically significant. There was a small but statistically significant 
decrease (4% and 5%, respectively) decrease in trabecular tissue mineral density (TMD) 
in CHet and CKO mice compared to CTR mice (Fig. 1E). The Osx-Cre transgene itself 
has no effect on femoral trabecular and cortical bone TMD (data not shown); thus, this 
indicated a role of FAK in regulating TMD. In femoral cortical bone of CKO mice, we 
observed a 24% decrease in cortical area (Fig. 1), a 15% decrease in cortical thickness 
(Fig. 1G), an 11% decrease in inner cortical bone perimeter (Fig. 1H), and a 12% 
decrease in outer cortical bone perimeter (Fig. 1I). Similar to trabecular bone, there was a 
small but statistically significant decrease (3% and 2%, respectively) in cortical bone 
TMD in cHet and CKO mice compared to CTR mice (Fig. 1J)  Of note, our previous data 
showed that the Osx-Cre transgene has minimal effect on the aforementioned femur bone 
parameters in C57BL/6 background mice.(15) In addition, CHet mice had comparable 
bone volume compared to CTR mice but had significantly higher bone volume compared 
to CKO mice. Besides femurs, µCT analysis was performed on calvaria. There was a 
decrease in bone mass in both calvarial parietal (Fig. 1K–O) and frontal (Supporting Fig. 
S3) bones of CKO mice compared to CTR mice. Taken together, our data showed that 
FAK deletion in osteoblasts leads to decreased bonemass in mice. 
<Insert Figure 1> 
Decreased bone mass in FAK-deficient mice is due to decreased osteoblastogenesis and 
associated with increased bone marrow adipogenesis 
To determine the cellular mechanisms of FAK regulation on bone development, we 
performed histomorphometry on femurs of CKO and CTR mice. Consistent with µCT 
measurements, we observed decreased bone area (BA/TA) (Fig. 2A), decreased 
trabecular number (Tb.N) (Fig. 2B), decreased trabecular thickness (Fig. 2C), and 
increased trabecular spacing (Fig. 2D) in the femur of CKO mice. The osteoblast number 
(N.Ob/BS) (Fig. 2E) and surface (Ob.S/BS) (Fig. 2F), but not the osteoclast number 
(N.Oc/BS) (Fig. 2G) and surface (Oc.S/BS) (Fig. 2H), were reduced by the deletion of 
FAK in CKO mice. Furthermore, there were significantly increased bone marrow 









osteoblastogenesis associated with increased adipogenesis in vivo contributed to 
decreased bone mass in CKO mice. 
<Insert Figure 2> 
FAK deletion leads to decreased BMSC proliferation and compromised osteoblast 
differentiation 
To further determine the mechanism responsible for the decreased osteoblastogenesis 
observed in CKO mice, we investigated the effect of FAK deletion on osteoblast 
proliferation with the primary BMSC culture system. Of the cells in this culture system, 
95% were Osterix+ cells (data not shown). FAK was efficiently deleted in isolated 
BMSCs (Fig. 3A). FAK-deficient cells had compromised proliferation ability as indicated 
by decreased cell number and Ki67+ cells (Fig. 3B–D). We then evaluated the osteogenic 
differentiation ability of FAK-deficient cells. FAK-deficient cells had compromised early 
differentiation as indicated by decreased alkaline phosphatase activity at early culture and 
defective terminal differentiation as indicated by poor mineralization (Fig. 4A). The 
expression levels of critical osteoblast differentiation transcription factors including 
Runx2 and Osterix were significantly decreased in CKO cultures (Fig. 4B). The 
expression levels of osteoblast differentiation markers, including alkaline phosphatase 
(Alpl), bone sialoprotein (Bsp), Collagen, type I, alpha 1 (ColIa1), and osteocalcin (Ocn) 
were all significantly decreased in the CKO cultures (Fig. 4B). Taken together, our data 
suggested that both decreased proliferation and compro ised differentiation contribute to 
the decreased osteoblast number and bone mass in vivo. 
<Insert Figure 3> 
<Insert Figure 4> 
FAK deletion enhances the adipogenic potential of BMSCs 
Increased bone marrow adipocytes in CKO mice prompted us to assess the effect of FAK 
deletion on the adipogenic potential of BMSCs. Similar to osteogenic culture, the BMSCs 
were isolated from CTR and CKO mice and the FAK waseffectively deleted (Fig. 5A). 
When exposed to adipogenic medium, the FAK-deficient BMSCs exhibited enhanced 
adipogenic differentiation, as shown by many more cells with accumulation of lipid 
droplets (shown by Oil Red-O staining) in CKO culture than in CTR culture (Fig. 5B, C). 









differentiation, were increased in FAK-deficient BMSCs (Fig. 5D). Importantly, the 
expression levels of these adipogenic marker genes were increased even before the 
adipogenic induction (day 0). Of note, PPARγ is not only an adipogenic differentiation 
marker but also a vital transcription factor for adipogenic differentiation. PPARγ mRNA 
expression had a twofold increase before adipogenic induction, indicating an intrinsically 
enhanced adipogenic potential by FAK deletion. When cultured in adipogenic medium 
for 5 days, the expression increase of PPARγ was further augmented to fourfold in CKO 
culture. To address the molecular mechanisms whereby FAK deletion in BMSCs 
increases adipogenic ability, we next examined the expression level of other crucial 
adipogenic transcription factors in cultured BMSCs (Fig. 5E). Levels of mRNAs 
encoding CCAAT-enhancer-binding protein α (C/EBPα) and C/EBPβ both were 
increased in CKO culture. mRNA levels of zinc finger protein 423 (Zfp423), a regulator 
of PPARγ expression(22) were increased similar to PPARγ. Taken together, these results 
are consistent with the possibility that the increased adipogenesis caused by the deletion 
of FAK in BMSCs was attributable to the increased expr ssion of PPARγ, C/EBPα, 
C/EBPβ, and Zfp423, four essential transcription factors f  adipogenesis. 
<Insert Figure 5> 
FAK deficiency leads to decreased Wnt/β-catenin signaling in BMSCs 
Wnt/β-catenin signaling regulates the adipogenic potential of BMSCs.(9,10) To determine 
whether altered Wnt/β-catenin signaling might contribute to the shift of balance between 
osteogenic and adipogenic potential in FAK-deficient BMSCs, we examined the β-
catenin expression by Western blot and found reduced β-catenin level in FAK-deficient 
BMSCs throughout the osteoblast differentiation culture (Fig. 6A). Interestingly, the β-
catenin level was positively correlated to FAK expression level in control culture, further 
suggesting a role of FAK in regulating β-catenin level. Next, we examined the mRNA 
expression of Wnt target genes and found reduced expression of Axin2, Cnx43, and Lef1 
at all time points in FAK-deficient BMSCs (Fig. 6B). Therefore, deletion of FAK in 
BMSCs impairs Wnt signaling by downregulating its effector β-catenin. To further 
determine the underlying mechanism of attenuated Wnt/β-catenin signaling in FAK-
deficient BMSCs, we examined the mRNA expression of some canonical Wnt ligands 









Wnt1, Wnt3a, and Wnt10b (Fig. 7A). Phosphorylation of the N terminal Ser 9 for GSK3β 
has an inhibitory effect on GSK3 function.(24) Consistent with the decrease in β-catenin 
level, the level of phosphor-GSK3β (S9) was decreased in FAK-deficient BMSCs at the 
start of and during osteogenic differentiation (Fig. 7B), suggesting that increased 
degradation activity of the GSK3 complex is responsible for the increased β-catenin 
degradation and subsequent lower Wnt/β-catenin signaling. 
<Insert Figure 6> 
<Insert Figure 7> 
FAK deficiency does not alter the proliferation or differentiation in primary calvarial 
osteoblast cells 
To further determine the effect of FAK deletion on osteoblast proliferation and 
differentiation, we determined the differentiation potential of osteblastic cells isolated 
from newborn calvaria, which comprise a more differentiated osteoblast population. In 
contrast to BMSCs, we found that both the proliferation (Supporting Fig. S4) and 
differentiation (Supporting Fig. S5) were not compromised by FAK deletion in primary 
calvaria osteoblasts. In addition, the β-catenin level and mRNA expression of Wnt/β-
catenin target genes were comparable in FAK-deficient primary calvaria osteoblasts 
(Supporting Fig. S6). Together, the bone marrow and calvarial culture results suggested 
that FAK might function at an early phase in osteoprogenitor cell proliferation and 
differentiation. 
Discussion 
Osteoblast proliferation and differentiation are regulated by complex signaling networks 
and knowledge of the relationship between osteoblastogenesis and adipogenesis is 
important to our understanding of development and diseases affecting bone metabolism. 
In this work, we identified a new signaling pathway regulating the commitment of 
mesenchymal progenitors into the osteoblast/adipocyte lineage and the 
proliferation/osteogenic differentiation of BMSCs. Ablation of FAK in Osterix-
expression cells leads to osteopenia and a dramatic increase in bone marrow adipogenesis 
associated with decreased expression of several canonical Wnt ligands, increased GSK3 
activity, decreased β-catenin level, and decreased Wnt/β-catenin–mediated transcription. 









differentiation and favor osteoblast over adipocyte lin age commitment,(6,8–10) we propose 
that the decreased Wnt/β-catenin signaling may at least partially account for the 
decreased bone mass, increased bone marrow adiposity, decreased BMSC proliferation 
and osteogenic differentiation, and enhanced BMSC adipogenic differentiation (Fig. 8A, 
B). However, the extent that decreased Wnt/β-catenin signaling in FAK-deficient BMSCs 
is responsible for the osteopenia in CKO mice remains to be determined. 
<Insert Figure 8> 
 Early lineage mesenchymal cells have the ability to differentiate into various cell 
types including osteoblasts and adipocytes.(25) Activation of the Wnt/β-catenin signaling 
pathway promotes osteoblastogenesis and inhibits adipogenesis by regulating cell type–
specific transcription factors.(26) Overexpression of Wnt1 or Wnt10b, activators of Wnt/β-
catenin signaling, potently represses adipogenesis.(27,28) Conversely, inhibition of Wnt 
signaling in preadipocytes stimulates differentiation.(27,29,30) Stabilization of β-catenin can 
promote osteoblastogenesis and inhibit adipogenesis in a bone marrow–derived cell 
line.(26) Overexpression of β-catenin in preadipocytes can inhibit their maturation.(27) 
Repression of C/EBPα and PPARγ, two critical adipogenesis transcription factors, is a 
primary mechanism by which Wnt signaling inhibits the differentiation of mesenchymal 
cells toward adipocytes. In addition, β-catenin and PPARγ can functionally interact with 
each other and negatively regulate each other’s activity. (31,32) In FAK-deficient BMSCs, 
we found that Wnt/β-catenin signaling was severely compromised associated with 
increased expression of adipogenic transcription factors and decreased expression of 
osteogenic transcription factors, which could account for the aberrantly enhanced 
adipogenesis as well as decreased BMSC proliferation nd osteogenic differentiation. 
 The connection between FAK and Wnt/β-catenin signaling in BMSCs is not 
unexpected. Hyperactivation of either Wnt/β-catenin or FAK signaling was 
independently shown to promote numerous types of human cancers.(33,34) In Xenopus 
laevis embryos, FAK protein knockdown anteriorizes the embryo, which resembles that 
of embryo knockdown for canonical Wnt signaling.(35) In addition, Wnt3a expression is 
FAK-dependent in developing frog neural plate.(35) In MCF-7 cells, a human breast 
cancer cell line, FAK protein depletion reduces Wnt3 and Wnt3a expression.(35) The 









regulation on Wnt signaling pathway could be highly conserved among vertebrates. Here 
we present the evidence showing the similar FAK/Wnt regulation axis in mouse. 
 A previous report showed that loss of FAK in osteoblasts leads to delayed bone 
regeneration and defective bone matrix deposition in a fracture healing model as well as 
compromised osteoblast differentiation in clonally established cell lines.(13) Here we 
report that FAK plays important role in bone development and bone marrow osteoblast 
differentiation. Of note, different transgenic Cre mouse models were used in these two 
studies. In the aforementioned report, Cre recombinase is driven by 2.3 kb of the collagen 
type I (α)I promoter.(36) It is known that this promoter is active in mature osteoblasts.(36,37) 
In our current research, Cre recombinase is driven by the Osterix promoter, which is 
active in earlier osteoblast lineage cells.(8) Most recently, lineage-tracing experiments 
showed that Osterix-expressing cells labeled during early embryo development can give 
rise to both osteoblasts and adipocytes in vivo.(38) In contrast to the defective 
proliferation, differentiation, and Wnt/β-catenin signaling pathway in FAK-deficient 
BMSCs, there was no abnormality in the in vitro culture of FAK-deficient primary 
calvarial osteoblasts. It is not uncommon to observe the different effects of gene deletion 
on osteogenic differentiation between bone marrow osteoblasts and calvarial osteoblasts. 
The deletion of Pyk2, another FAK subfamily member, l ads to altered bone marrow 
osteoblast differentiation but not to more mature calvarial osteoblasts.(39) This disparity of 
the effects of FAK deletion in BMSCs versus calvarial osteoblasts may be due to several 
possible reasons. First, FAK deletion has cell origin–specific (bone marrow versus 
calvaria) effects on osteoblasts. However, there was also decreased calvarial bone mass in 
CKO mice, which argues against this possibility. Second, because BMSCs are a mixed 
cell population, there might be much fewer osteoblasts in BMSCs from CKO mice. In our 
BMSC culture system, we found that 97% of attached cells are Osterix+ prior to the 
osteogenic differentiation experiment (data not shown). Thus there were enriched 
Osterix+ cells in BMSC cultures comparable to that in calvarial cultures. Third, FAK 
deletion has a differentiation stage–specific (progenitor versus more mature) effect on 
osteoblast function. Even though calvarial osteoblasts re also originally from Osterix-
expressing osteoprogenitor cells in vivo, the isolated calvarial cells represent a more 









β-catenin level at both early and late culture, which might seem against this possibility. 
However, our data also demonstrated that the β-catenin level positively correlated with 
the FAK level during BMSC osteogenic culture and both FAK and β-catenin levels were 
increased during differentiation in control culture. Thus, the decrease in β-catenin level in 
CKO BMSC culture at later differentiation stages may be secondary to the differentiation 
defect. 
 Conditional β-catenin deletion in mature osteoblastic lineage cells l ads to an 
osteopenia phenotype through the increase in osteoblast genesis as a result of increased 
expression of osteoprotegerin (OPG), a major inhibitor of osteoclast differentiation.(40,41) 
In FAK CKO mice with the Osx-Cre driver, our data showed that osteoclast number was 
not affected. This may explain the phenotypic difference between the β-catenin CKO 
model and the FAK CKO model when later osteoblastic lineage cells are targeted. 
However, it is unknown whether there is alteration in osteoclastogenesis (or 
osteoblastogenesis) in FAK CKO mice with the Col2.3-Cre model.(13) 
 Our findings suggest that in Osterix-expressing cells, FAK promotes Wnt 
signaling, thereby increasing the number of matrix-synthesizing osteoblasts by promoting 
their proliferation and decreasing their adipocyte lin age commitment, and enhancing 
their osteogenic differentiation, and thus ultimately increases bone mass. It has been 
reported that Osterix-Cre targets multiple cell types besides the osteoblast lineage in 
postnatal mice.(42) Thus, the bone phenotype is potentially contributed by other non-
osteoblast lineage cells. Noteworthy, the skeletal phenotype of FAK CKO mice is much 
milder than that of β-catenin CKO mice using the same Cre driver,(8) which may reflect 
the fact that β-catenin was decreased but not ablated in FAK CKO mice. The finding that 
FAK signaling plays a critical role in determining bone and marrow fat mass presents us 
caution about the skeletal consequence of using FAKsignaling inhibitors in treating 
various cancer patients.(14) Because FAK inhibitor administration inhibits FAK activity 
systemically, it would be important to understand how FAK inhibition could affect the 
function of earlier mesenchymal lineage cells, which could not be addressed by the 
Osterix-Cre model and warrants the use of other mouse models. 
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Fig. 1. Mice with FAK deletion exhibit reduced bone mass. µCT measurements were 
performed in femurs (A–J), and parietal bones (K–O) of 2-month-old male FAKF/F 
(CTR), FAKF/+;Osx-Cre (CHet), and FAKF/F;Osx-Cre (CKO) mice. (A–E)Trabecular 
parameters of femur: BV/TV, bone volume per tissue volume (A); Tb.N, trabecular 
number (B); Tb.Th, trabecular thickness (C); Tb.Sp, trabecular spacing (D); and TMD, 









thickness (G); inner perimeter of cortical bone (H); outer perimeter of cortical bone (I); 
TMD (J). (K–O) Measurement of parietal bone: bone volume (K); BV/TV (L); BMD, 
bone mineral density (M); parietal thickness (N); TMD (O). *p < 0.05, #0.05 < p < 0.1, n 
= 9 to 13 per group for femoral group, n = 5 to 6 per group for calvarial group. Values are 
presented as mean + SE. 
Fig. 2. FAK deletion in mice leads to decreased osteoblast ut increased bone marrow 
adipocyte number. Histomorphometry analysis was performed in femur of 2-month-old 
FAKF/F (CTR) and FAKF/F;Osx-Cre (CKO) male mice. (A) BA/TA, bone area per tissue 
area. (B) Tb.N, trabecular bone number. (C) Tb.Th, trabecular thickness. (D) Tb.Sp, 
trabecular spacing. (E) N.Ob/BS, osteoblast number. (F) Ob.S/BS, osteoblast surface. (G) 
Osteoclast number. (H) Osteoclast surface. (I) N.Ad/BA, adipocyte number. (J) 
Histological images showing bone marrow adipocytes (indicated by arrows). *p < 0.05, n 
= 6 to 9. Values are presented as mean + SE. 
Fig. 3. FAK-deficient BMSCs have decreased proliferation. (A) FAK expression (left 
panel) and quantification (right) analyzed by Western blot in BMSCs isolated from CTR 
and CKO mice (n = 7 per group). (B) Quantitative analysis of cell number cultured for 3 
and 7 days in osteogenic medium (n = 4 per group). (C) Quantification of Ki67-positive 
BMSCs in the cultures described in B (n = 3 per group). (D) Representative fluorescent 
images of Ki67 (red) and Dapi (blue) staining in FAK CTR and CKO BMSCs at 3rd and 
7th day, in the same cultures system as described in B. *p < 0.05. Values are presented as 
mean + SE. 
Fig. 4. FAK deletion compromises BMSCs osteoblast differentiation. (A) Osteoblast 
differentiation and mineralization from BMSCs cultured in osteogenic medium were 
analyzed by alkaline phosphatase (ALP) and alizarin red (AR) staining at the indicated 
time points. Images shown were the representatives of six independent experiments. (B) 
Quantitative PCR analysis of the mRNA expression of osteoblast differentiation markers, 
in the cultures described in A. Osx = osterix; Alpl = alkaline phosphatase; Bsp = bone 
sialoprotein protein; ColIa1 = collagen, type I, alpha 1; Ocn = osteocalcin. *p < 0.05 n = 
3. Values are presented as mean + SE. 
Fig. 5. FAK-deficient BMSCs have enhanced adipogenesis. (A) FAK was deleted in 









differentiation of FAK-deficient BMSCs, in adipogenic medium for 5 days. (C) The 
quantification of Oil red O staining described in B. (D, E) Quantitative PCR analysis of 
the mRNA expression of adipogenic differentiation markers (D) and transcription factors 
that is critical for adipogenic differentiation (E), in the cultures described in B. *p < 0.05 
n = 3. Values are presented as mean + SE. 
Fig. 6. FAK deficiency impairs Wnt/β-catenin signaling pathway. (A) Immunoblotting 
analysis (left) and quantification of FAK (middle) and β-catenin (right) protein level in 
BMSCs osteoblast differentiation cultures described in Fig. 4. (B) Quantitative PCR 
analysis of Wnt/β-catenin target gene expression during osteoblast differentiation. *p < 
0.05, n = 4. Values are presented as mean + SE. 
Fig. 7. FAK regulates Wnt/β-catenin signaling through Wnt ligand/GSK3 pathway. (A) 
mRNA levels of Wnt ligands (Wnt1, Wnt3a, and Wnt10b) by quantitative PCR in 
BMSCs osteoblast differentiation culture described in Fig. 4. (B) Protein levels of 
phosphor-GSK3β (p-GSK3β) at S9 by Western blot (left), in the same culture shown in 
A. The relative level of p-GSK3β is shown in the right panel. *p < 0.05, n = 3. Values are 
presented as mean + SE. 
Fig. 8. Model of the role of FAK in regulating lineage commitment, proliferation, and 
osteogenic differentiation of BMSCs. (A) Wnt/β-catenin signaling pathway inhibits 
adipogenic differentiation of BMSCs but promotes their osteoblast lineage commitment, 
and positively regulates osteoblast proliferation and differentiation. (B) Ablation of FAK 
in early bone marrow osteoblast progenitors attenuates the expression of canonical Wnt 
ligands, increases GSK3 activity, decreases β-catenin level, and ultimately impairs 
Wnt/β-catenin–mediated transcription, which can account for the reduced BMSCs 
proliferation and osteogenic differentiation, but enhanced BMSCs adipogenic 
differentiation, and thereby contributes to the decreased bone mass and increased bone 
marrow adiposity. “+” indicates positive effect of Wnt/β-catenin signaling and “–” 
indicates inhibitory effect of Wnt/β-catenin signaling. “+++” and “–––” indicate stronger 
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